Quick Summary:
In the ever-evolving world of healthcare diagnostics, staying informed and ahead of the curve is paramount. The Global Breast Lesion Localization Market is projected to reach a significant value of US$ 387.7 Million by 2030, up from an estimated US$271.4 Million in 2022. This comprehensive market research report offers valuable insights into this progressive sector, underlining not just its current status but also the future trends and growth potential.
The report's broad scope covers key segments including Breast Biopsy, Lumpectomy and geographic markets like the U.S., China, Japan and Canada. It profiles and critically evaluates industry leaders, providing an evaluation of their market shares and competitive standing. With a focus on knowledge and foresight, this is an indispensable resource for those looking to understand, evaluate, and leverage the potential of the Breast Lesion Localization market.
Global Breast Lesion Localization Market to Reach $387.7 Million by 2030
The global market for Breast Lesion Localization estimated at US$271.4 Million in the year 2022, is projected to reach a revised size of US$387.7 Million by 2030, growing at a CAGR of 4.6% over the analysis period 2022-2030. Breast Biopsy, one of the segments analyzed in the report, is projected to record 5% CAGR and reach US$279.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Lumpectomy segment is readjusted to a revised 3.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $81.3 Million, While China is Forecast to Grow at 4.2% CAGR
The Breast Lesion Localization market in the U.S. is estimated at US$81.3 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$67.8 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 3.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.Select Competitors (Total 43 Featured) -
- Argon Medical Devices, Inc.
- BARD, A Becton, Dickinson Company
- Cianna Medical, Inc.
- Cook Medical LLC
- CP Medical Corporation
- Somatex Medical Technologies GmbH
- Sterylab Srl
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Breast Lesion Localization?
What is the growth rate of the Global Market for Breast Lesion Localization?
What is the forecasted size of the Global Market for Breast Lesion Localization?
Who are the key companies in the Global Market for Breast Lesion Localization?
| Report Attribute | Details |
|---|---|
| No. of Pages | 193 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 271.4 Million |
| Forecasted Market Value ( USD | $ 387.7 Million |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Argon Medical Devices, Inc.
- BARD, A Becton, Dickinson Company
- Cianna Medical, Inc.
- Cook Medical LLC
- CP Medical Corporation
- Somatex Medical Technologies GmbH
- Sterylab Srl
